Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FLDM

Fluidigm (FLDM) Stock Price, News & Analysis

Fluidigm logo

About Fluidigm Stock (NASDAQ:FLDM)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$3.27
$3.99
52-Week Range
N/A
Volume
60,126 shs
Average Volume
968,838 shs
Market Capitalization
$283.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FLDM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fluidigm and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

FLDM Stock News Headlines

This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.tc pixel
Here's what Wall Street expects from Fluidigm's earnings
T2 Biosystms Inc (TTOO)
Standard BioTools (NASDAQ: FLDM)
See More Headlines

FLDM Stock Analysis - Frequently Asked Questions

Fluidigm Co. (NASDAQ:FLDM) posted its quarterly earnings data on Sunday, November, 7th. The medical research company reported ($0.18) earnings per share for the quarter, topping the consensus estimate of ($0.22) by $0.04. The medical research company earned $28.50 million during the quarter. Fluidigm had a negative trailing twelve-month return on equity of 40.15% and a negative net margin of 45.36%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Fluidigm investors own include Himax Technologies (HIMX), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Moderna (MRNA), Pfizer (PFE), Accelerate Diagnostics (AXDX) and Meta Platforms (META).

Company Calendar

Last Earnings
11/07/2021
Today
8/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Analytical Instruments
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NASDAQ:FLDM
CIK
1162194
Employees
615
Year Founded
1999

Profitability

EPS (Trailing Twelve Months)
($0.78)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$59.24 million
Net Margins
-45.36%
Pretax Margin
-48.75%
Return on Equity
-40.15%
Return on Assets
-14.86%

Debt

Debt-to-Equity Ratio
0.68
Current Ratio
1.45
Quick Ratio
1.03

Sales & Book Value

Annual Sales
$130.58 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.24 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
76,486,000
Free Float
74,268,000
Market Cap
$283.76 million
Optionable
Optionable
Beta
1.14

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:FLDM) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners